Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Oncobiologics (OTLK) SEC Filings & 10K Form

Oncobiologics logo
$2.68 +0.27 (+11.20%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$2.72 +0.03 (+1.31%)
As of 08/22/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Oncobiologics SEC Filings

Export to Excel
DateFilerForm TypeView
08/14/2025
4:15 PM		GREAT POINT PARTNERS LLC (Filed by)
Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
Form SCHEDULE 13G/A
08/14/2025
3:15 PM		Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G/A
07/09/2025
4:16 PM		Jahr Robert Charles (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2025
4:17 PM		Jahr Robert Charles (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
3:31 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
4:00 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
4:24 PM		GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
Form SCHEDULE 13D/A
05/28/2025
4:20 PM		GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Sukhtian Ghiath M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:36 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 424B5
04/10/2025
4:28 PM		Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SCHEDULE 13G/A
03/30/2025
11:15 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form EFFECT
03/28/2025
3:44 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 424B3
03/12/2025
8:11 PM		GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
Form SCHEDULE 13D/A
03/12/2025
7:56 PM		GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Sukhtian Ghiath M. (Reporting)
Form 4/A
03/09/2025
11:15 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form EFFECT
02/28/2025
3:37 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/28/2025
7:17 AM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:38 PM		Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
Form SCHEDULE 13G/A
02/14/2025
7:14 AM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
3:16 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form DEF 14A
02/10/2025
3:19 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form ARS
02/06/2025
3:40 PM		Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:46 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form PRE 14A
01/31/2025
3:39 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
4:04 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/23/2025
4:00 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 10-K/A
01/22/2025
3:17 PM		GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
Form SCHEDULE 13D/A
01/16/2025
4:16 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:30 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/27/2024
7:14 AM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
3:11 PM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2024
6:27 AM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
11:26 AM		Outlook Therapeutics, Inc. (Filer)
Oncobiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:55 PM		GREAT POINT PARTNERS LLC (Filed by)
Outlook Therapeutics, Inc. (Subject)
Oncobiologics (Subject)
Form SC 13G/A
10/03/2024
8:22 PM		Gangolli Julian S (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
THURMAN RANDY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		HILZINGER KURT J (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Auffarth Gerd (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel

Discover the under-the-radar project I believe will skyrocket as a result.
10/03/2024
7:30 PM		Haller Julia A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:53 PM		KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Oncobiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:OTLK) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel